| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Predicted |
|---|
| Creation Date | 2021-08-30 18:02:21 UTC |
|---|
| Update Date | 2022-11-15 17:47:02 UTC |
|---|
| HMDB ID | HMDB0242393 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | Chenodeoxycholylcysteine |
|---|
| Description | Chenodeoxycholylcysteine belongs to the class of organic compounds known as glycinated bile acids and derivatives. Glycinated bile acids and derivatives are compounds with a structure characterized by the presence of a glycine linked to a bile acid skeleton. Based on a literature review very few articles have been published on Chenodeoxycholylcysteine. |
|---|
| Structure | CC(CCC(=O)NC(CS)C(O)=O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CCC12C InChI=1S/C27H45NO5S/c1-15(4-7-23(31)28-21(14-34)25(32)33)18-5-6-19-24-20(9-11-27(18,19)3)26(2)10-8-17(29)12-16(26)13-22(24)30/h15-22,24,29-30,34H,4-14H2,1-3H3,(H,28,31)(H,32,33) |
|---|
| Synonyms | | Value | Source |
|---|
| Chenodeoxycholylcysteine | HMDB | | Cys-Chenodeoxycho | HMDB | | Cys-CDCA | HMDB | | Cystochenodeoxycholic acid | HMDB | | Cystochenodeoxycholate | HMDB |
|
|---|
| Chemical Formula | C27H45NO5S |
|---|
| Average Molecular Weight | 495.72 |
|---|
| Monoisotopic Molecular Weight | 495.301844727 |
|---|
| IUPAC Name | 2-(4-{5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}pentanamido)-3-sulfanylpropanoic acid |
|---|
| Traditional Name | 2-(4-{5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}pentanamido)-3-sulfanylpropanoic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC(CCC(=O)NC(CS)C(O)=O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CCC12C |
|---|
| InChI Identifier | InChI=1S/C27H45NO5S/c1-15(4-7-23(31)28-21(14-34)25(32)33)18-5-6-19-24-20(9-11-27(18,19)3)26(2)10-8-17(29)12-16(26)13-22(24)30/h15-22,24,29-30,34H,4-14H2,1-3H3,(H,28,31)(H,32,33) |
|---|
| InChI Key | RIGHMQLKMHLMQD-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as glycinated bile acids and derivatives. Glycinated bile acids and derivatives are compounds with a structure characterized by the presence of a glycine linked to a bile acid skeleton. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Steroids and steroid derivatives |
|---|
| Sub Class | Bile acids, alcohols and derivatives |
|---|
| Direct Parent | Glycinated bile acids and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Glycinated bile acid
- Dihydroxy bile acid, alcohol, or derivatives
- Hydroxy bile acid, alcohol, or derivatives
- 7-hydroxysteroid
- Hydroxysteroid
- 3-hydroxysteroid
- N-acyl-alpha amino acid or derivatives
- N-acyl-alpha-amino acid
- Cysteine or derivatives
- Alpha-amino acid or derivatives
- Fatty acyl
- N-acyl-amine
- Fatty amide
- Cyclic alcohol
- Secondary carboxylic acid amide
- Secondary alcohol
- Carboxamide group
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Alkylthiol
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Carbonyl group
- Alcohol
- Aliphatic homopolycyclic compound
|
|---|
| Molecular Framework | Aliphatic homopolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | Not Available |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross Sections| Predictor | Adduct Type | CCS Value (Å2) | Reference |
|---|
| DeepCCS | [M-2H]- | 250.747 | 30932474 | | DeepCCS | [M+Na]+ | 225.976 | 30932474 |
Predicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 16.2378 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.35 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 3595.7 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 214.1 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 222.7 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 175.0 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 579.4 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 711.1 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 762.7 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 124.6 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1224.8 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 563.3 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1943.8 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 412.2 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 490.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 224.0 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 222.3 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 58.0 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Chenodeoxycholylcysteine,4TMS,isomer #1 | CC(CCC(=O)NC(CS[Si](C)(C)C)C(=O)O[Si](C)(C)C)C1CCC2C3C(O[Si](C)(C)C)CC4CC(O[Si](C)(C)C)CCC4(C)C3CCC12C | 4127.0 | Semi standard non polar | 33892256 | | Chenodeoxycholylcysteine,4TMS,isomer #1 | CC(CCC(=O)NC(CS[Si](C)(C)C)C(=O)O[Si](C)(C)C)C1CCC2C3C(O[Si](C)(C)C)CC4CC(O[Si](C)(C)C)CCC4(C)C3CCC12C | 4120.1 | Standard non polar | 33892256 | | Chenodeoxycholylcysteine,4TMS,isomer #1 | CC(CCC(=O)NC(CS[Si](C)(C)C)C(=O)O[Si](C)(C)C)C1CCC2C3C(O[Si](C)(C)C)CC4CC(O[Si](C)(C)C)CCC4(C)C3CCC12C | 4536.3 | Standard polar | 33892256 | | Chenodeoxycholylcysteine,4TMS,isomer #2 | CC(CCC(=O)N(C(CS)C(=O)O[Si](C)(C)C)[Si](C)(C)C)C1CCC2C3C(O[Si](C)(C)C)CC4CC(O[Si](C)(C)C)CCC4(C)C3CCC12C | 4056.1 | Semi standard non polar | 33892256 | | Chenodeoxycholylcysteine,4TMS,isomer #2 | CC(CCC(=O)N(C(CS)C(=O)O[Si](C)(C)C)[Si](C)(C)C)C1CCC2C3C(O[Si](C)(C)C)CC4CC(O[Si](C)(C)C)CCC4(C)C3CCC12C | 4053.8 | Standard non polar | 33892256 | | Chenodeoxycholylcysteine,4TMS,isomer #2 | CC(CCC(=O)N(C(CS)C(=O)O[Si](C)(C)C)[Si](C)(C)C)C1CCC2C3C(O[Si](C)(C)C)CC4CC(O[Si](C)(C)C)CCC4(C)C3CCC12C | 4424.8 | Standard polar | 33892256 | | Chenodeoxycholylcysteine,4TMS,isomer #3 | CC(CCC(=O)N(C(CS[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C)C1CCC2C3C(O[Si](C)(C)C)CC4CC(O)CCC4(C)C3CCC12C | 4182.6 | Semi standard non polar | 33892256 | | Chenodeoxycholylcysteine,4TMS,isomer #3 | CC(CCC(=O)N(C(CS[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C)C1CCC2C3C(O[Si](C)(C)C)CC4CC(O)CCC4(C)C3CCC12C | 4224.8 | Standard non polar | 33892256 | | Chenodeoxycholylcysteine,4TMS,isomer #3 | CC(CCC(=O)N(C(CS[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C)C1CCC2C3C(O[Si](C)(C)C)CC4CC(O)CCC4(C)C3CCC12C | 4597.5 | Standard polar | 33892256 | | Chenodeoxycholylcysteine,4TMS,isomer #4 | CC(CCC(=O)N(C(CS[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C)C1CCC2C3C(O)CC4CC(O[Si](C)(C)C)CCC4(C)C3CCC12C | 4253.2 | Semi standard non polar | 33892256 | | Chenodeoxycholylcysteine,4TMS,isomer #4 | CC(CCC(=O)N(C(CS[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C)C1CCC2C3C(O)CC4CC(O[Si](C)(C)C)CCC4(C)C3CCC12C | 4281.0 | Standard non polar | 33892256 | | Chenodeoxycholylcysteine,4TMS,isomer #4 | CC(CCC(=O)N(C(CS[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C)C1CCC2C3C(O)CC4CC(O[Si](C)(C)C)CCC4(C)C3CCC12C | 4682.1 | Standard polar | 33892256 | | Chenodeoxycholylcysteine,4TMS,isomer #5 | CC(CCC(=O)N(C(CS[Si](C)(C)C)C(=O)O)[Si](C)(C)C)C1CCC2C3C(O[Si](C)(C)C)CC4CC(O[Si](C)(C)C)CCC4(C)C3CCC12C | 4171.1 | Semi standard non polar | 33892256 | | Chenodeoxycholylcysteine,4TMS,isomer #5 | CC(CCC(=O)N(C(CS[Si](C)(C)C)C(=O)O)[Si](C)(C)C)C1CCC2C3C(O[Si](C)(C)C)CC4CC(O[Si](C)(C)C)CCC4(C)C3CCC12C | 4160.8 | Standard non polar | 33892256 | | Chenodeoxycholylcysteine,4TMS,isomer #5 | CC(CCC(=O)N(C(CS[Si](C)(C)C)C(=O)O)[Si](C)(C)C)C1CCC2C3C(O[Si](C)(C)C)CC4CC(O[Si](C)(C)C)CCC4(C)C3CCC12C | 4622.9 | Standard polar | 33892256 | | Chenodeoxycholylcysteine,5TMS,isomer #1 | CC(CCC(=O)N(C(CS[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C)C1CCC2C3C(O[Si](C)(C)C)CC4CC(O[Si](C)(C)C)CCC4(C)C3CCC12C | 4078.7 | Semi standard non polar | 33892256 | | Chenodeoxycholylcysteine,5TMS,isomer #1 | CC(CCC(=O)N(C(CS[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C)C1CCC2C3C(O[Si](C)(C)C)CC4CC(O[Si](C)(C)C)CCC4(C)C3CCC12C | 4193.7 | Standard non polar | 33892256 | | Chenodeoxycholylcysteine,5TMS,isomer #1 | CC(CCC(=O)N(C(CS[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C)C1CCC2C3C(O[Si](C)(C)C)CC4CC(O[Si](C)(C)C)CCC4(C)C3CCC12C | 4409.8 | Standard polar | 33892256 |
|
|---|